Office of Medicaid Evaluation

Antiretroviral Improvement among Medicaid enrolleeS (AIMS)

Retention in HIV care and HIV medication adherence are major public health challenges. Data to care is a public health strategy that uses health department surveillance data to support retention in HIV care. However, this approach has challenges with the timeliness of data reporting. A new direction is insurance-based data to care, which uses HIV prescription records from insurance claims to more rapidly identify those at risk of loss from HIV care.

Our goals are to evaluate the Antiretroviral Improvement among Medicaid EnrolleeS (AIMS) study, which leverages real-time HIV prescription claims from Virginia Medicaid and HIV surveillance data from Virginia Department of Health in a statewide cluster-randomized, controlled trial in order to compare a phased, multi-level program of support (intervention) to usual care, among Virginia Medicaid enrollees without current ART prescriptions.

July 2025

Kimmel AD, Byrd KK, Stirratt M, Harris D, Stallings R, Bono RS, Mitchell A, Dillingham R, Palmer C, Popoff E, Pan Z, Ingersoll K, Dahman B; AIMS study team. Study Protocol(s) for Antiretroviral Improvement among Medicaid EnrolleeS (AIMS): A Cluster-Randomized Controlled Trial Leveraging Real-time Administrative Claims to Support Antiretroviral Prescription Adherence. Contemp Clin Trials. 2025 Jul;154:107959.

April 2024

Kimmel AD. Barriers to D2C Rx: Insights from the AIMS Study. Panelist, Using prescription data to support the HIV care continuum. CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC). April 9-10, 2024.